Evidence map›Paper›PMID 32920666›Full record

ArticleMedical oncology (Northwood, London, England)2020

Prospective evaluation of

Liang Dong, Yinjie Zhu, Mei Xin, Baijun Dong, Jiahua Pan, Jianjun Liu, Sarah R Amend, Wei Xue, Kenneth J Pienta, Steven P Rowe

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Distinct prognostic value of [Communications medicine · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Liang DongDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd., Surgery building Room 1610, Shanghai, China.ORCID http://orcid.org/0000-0001-7689-3237
Yinjie ZhuDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd., Surgery building Room 1610, Shanghai, China.
Mei XinDepartment of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd., Nuclear Medicine Center Room 205, Shanghai, China.
Baijun DongDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd., Surgery building Room 1610, Shanghai, China.
Jiahua PanDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd., Surgery building Room 1610, Shanghai, China.
Jianjun LiuDepartment of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd., Nuclear Medicine Center Room 205, Shanghai, China. nuclearj@163.com.
Sarah R AmendThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, 601 N. Caroline St., JHOC Room 3233, Baltimore, MD, USA.
Wei XueDepartment of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, 160 Pujian Rd., Surgery building Room 1610, Shanghai, China. uroxuewei@163.com.
Kenneth J PientaThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, 601 N. Caroline St., JHOC Room 3233, Baltimore, MD, USA.
Steven P RoweThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, 601 N. Caroline St., JHOC Room 3233, Baltimore, MD, USA. srowe8@jhmi.edu.ORCID http://orcid.org/0000-0003-2897-4694
Shanghai Jiao Tong University · CNJohns Hopkins University · US

Funding

Tumor microvesicle-mediated modulation of the bone microenvironmentP01CA093900 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PIENTA, KENNETH J. · 2004 to 2024
$29.6M
TRANS_NETWORK PROJECTSU54CA143803 · NCI · PRINCETON UNIVERSITY · PI GETZENBERG, ROBERT H. · 2009 to 2013
$14.2M
Mechanisms That Regulate Dormancy of Disseminated Tumor Cells in the Bone MarrowU54CA163124 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHIOZAWA, YUSUKE · 2011 to 2015
$3.0M
Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer ProgressionU01CA143055 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PIENTA, KENNETH J., ROWLEY, DAVID R · 2010 to 2014
$2.7M
National Natural Science Foundation of China 81701725Natural Science Foundation of Shanghai 17ZR1447400NCI NIH HHS CA093900NCI NIH HHS CA143055NCI NIH HHS CA163124NCI NIH HHS U54CA143803Program for Outstanding Medical Academic Leader 2019LJ11Program of Shanghai Subject Chief Scientist 19XD1402300Shanghai Rising-Star Program SHDC2012105
6 · The paper itself

Abstract

The purpose of this study was to prospectively evaluate the distribution of PSMA-targeted, PET-avid lesions in prostate cancer (PCa) patients with biochemical recurrence in a Chinese cohort. The relationships between PSA levels, disease-free time after prostatectomy, and

Indexed as

AdenocarcinomaAgedAged, 80 and overAsian PeopleGallium IsotopesGallium RadioisotopesHumansMaleMiddle AgedNeoplasm Recurrence, LocalPositron Emission Tomography Computed TomographyProspective StudiesProstatectomyProstate-Specific AntigenProstatic NeoplasmsRadiopharmaceuticalsgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesProstate-Specific AntigenRadiopharmaceuticalsBiochemical recurrenceProstate cancerProstate-specific membrane antigen

Identifiers

PMID32920666
OpenAlexW3085058955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.